Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?
- 30 November 2009
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 41 (11), 2098-2108
- https://doi.org/10.1016/j.biocel.2009.05.015
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Interaction of Bupropion with Muscle-Type Nicotinic Acetylcholine Receptors in Different Conformational StatesBiochemistry, 2009
- Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and TherapeuticsAnnual Review of Pharmacology and Toxicology, 2009
- Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptorsThe International Journal of Biochemistry & Cell Biology, 2006
- Molecular Mechanisms and Binding Site Location for the Noncompetitive Antagonist Crystal Violet on Nicotinic Acetylcholine ReceptorsBiochemistry, 2006
- Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc-TRODAT-1 SPECT studyJournal of Affective Disorders, 2005
- Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by BupropionJournal of Pharmacology and Experimental Therapeutics, 2005
- Noncompetitive Antagonist Binding Sites in the Torpedo Nicotinic Acetylcholine Receptor Ion Channel. Structure−Activity Relationship Studies Using Adamantane DerivativesBiochemistry, 2003
- Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled TrialObesity Research, 2002
- Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channelArchives of Biochemistry and Biophysics, 2002
- Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortexSynapse, 1991